{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T21:26:39Z","timestamp":1771190799229,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ejrad.2022.110499","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T19:19:17Z","timestamp":1661627957000},"page":"110499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Differentiating EGFR from ALK mutation status using radiomics signature based on MR sequences of brain metastasis"],"prefix":"10.1016","volume":"155","author":[{"given":"Ye","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinna","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zexuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yichuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dailun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejrad.2022.110499_b0005","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/01.wco.0000191514.37498.2b","article-title":"Brain metastases","volume":"18","author":"Norden","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ejrad.2022.110499_b0010","doi-asserted-by":"crossref","unstructured":"C. Nolan, L.M. Deangelis, Overview of metastatic disease of the central nervous system, Handbook of clinical neurology. 149 (2018) 3\u201323. https:\/\/doi.org\/10.1016\/B978-0-12-811161-1.00001-3.","DOI":"10.1016\/B978-0-12-811161-1.00001-3"},{"issue":"7","key":"10.1016\/j.ejrad.2022.110499_b0015","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1468-1331.2006.01506.x","article-title":"EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force","volume":"13","author":"Soffietti","year":"2006","journal-title":"Eur. J. Neurol."},{"issue":"30","key":"10.1016\/j.ejrad.2022.110499_b0020","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1200\/JCO.2015.60.9503","article-title":"Treatment of Brain Metastases","volume":"33","author":"Lin","year":"2015","journal-title":"J. Clin. Oncol.: Offi. J. Am. Soc. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ejrad.2022.110499_b0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1756-9966-30-30","article-title":"Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice","volume":"30","author":"Sun","year":"2011","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"issue":"4","key":"10.1016\/j.ejrad.2022.110499_b0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.cllc.2011.09.004","article-title":"Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC)","volume":"13","author":"Reungwetwattana","year":"2012","journal-title":"Clin Lung Cancer."},{"issue":"1","key":"10.1016\/j.ejrad.2022.110499_b0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.lungcan.2015.01.020","article-title":"Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers","volume":"88","author":"Rangachari","year":"2015","journal-title":"Lung Cancer (Amsterdam, Netherlands)."},{"issue":"12","key":"10.1016\/j.ejrad.2022.110499_b0040","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/1758834017736252","article-title":"Targeted therapy of brain metastases: latest evidence and clinical implications","volume":"9","author":"Di Lorenzo","year":"2017","journal-title":"Therap. Adv. Med Oncol."},{"issue":"5","key":"10.1016\/j.ejrad.2022.110499_b0045","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1349-7006.2008.00782.x","article-title":"Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib","volume":"99","author":"Taniguchi","year":"2008","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.ejrad.2022.110499_b0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13045-016-0277-y","article-title":"Current status and perspectives in translational biomarker research for PD-1\/PD-L1 immune checkpoint blockade therapy","volume":"9","author":"Ma","year":"2016","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.ejrad.2022.110499_b0055","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cncy.21322","article-title":"EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients","volume":"121","author":"Malapelle","year":"2013","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ejrad.2022.110499_b0060","unstructured":"M. Ilie, V. Hofman, E. Long, O. Bordone, E. Selva, K. Washetine, C.H. Marquette, P. Hofman, Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?, Ann. Transl. Med. 2 (11) (2014) 107. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2014.08.11."},{"issue":"5","key":"10.1016\/j.ejrad.2022.110499_b0065","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrneurol.2017.44","article-title":"Advances in neuro-oncology imaging","volume":"13","author":"Langen","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.ejrad.2022.110499_b0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13244-020-00887-2","article-title":"Radiomics in medical imaging-\u201chow-to\u201d guide and critical reflection","volume":"11","author":"van Timmeren","year":"2020","journal-title":"Insights into Imaging."},{"key":"10.1016\/j.ejrad.2022.110499_b0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.lungcan.2019.03.025","article-title":"Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology","volume":"132","author":"Tu","year":"2019","journal-title":"Lung Cancer (Amsterdam, Netherlands)."},{"key":"10.1016\/j.ejrad.2022.110499_b0080","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.2147\/OTT.S257798","article-title":"Evaluating Solid Lung Adenocarcinoma Anaplastic Lymphoma Kinase Gene Rearrangement Using Noninvasive Radiomics Biomarkers","volume":"13","author":"Ma","year":"2020","journal-title":"OncoTargets Therapy"},{"issue":"9","key":"10.1016\/j.ejrad.2022.110499_b0085","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1007\/s00330-022-08673-y","article-title":"Predicting EGFR mutation status in lung adenocarcinoma presenting as ground-glass opacity: utilizing radiomics model in clinical translation","volume":"32","author":"Cheng","year":"2022","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2022.110499_b0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fonc.2020.00057","article-title":"CT-Based Radiomic Signature as a Prognostic Factor in Stage IV ALK-Positive Non-small-cell Lung Cancer Treated With TKI Crizotinib: A Proof-of-Concept Study","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejrad.2022.110499_b0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mri.2020.03.002","article-title":"Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases","volume":"69","author":"Chen","year":"2020","journal-title":"Magnet. Resonan. Imag."},{"issue":"6","key":"10.1016\/j.ejrad.2022.110499_b0100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/15384047.2017.1323580","article-title":"Current status of research and treatment for non-small cell lung cancer in never-smoking females","volume":"18","author":"Saito","year":"2017","journal-title":"Cancer Biol. Therapy."},{"key":"10.1016\/j.ejrad.2022.110499_b0105","doi-asserted-by":"crossref","unstructured":"S.J. Rodig, M. Mino-Kenudson, S. Dacic, B.Y. Yeap, A. Shaw, J.A. Barletta, H. Stubbs, K. Law, N. Lindeman, E. Mark, P.A. Janne, T. Lynch, B.E. Johnson, A.J. Iafrate, L.R. Chirieac, Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 15 (16) (2009) 5216\u20135223. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-0802.","DOI":"10.1158\/1078-0432.CCR-09-0802"},{"key":"10.1016\/j.ejrad.2022.110499_b0110","doi-asserted-by":"crossref","first-page":"103194","DOI":"10.1016\/j.critrevonc.2020.103194","article-title":"Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives","volume":"157","author":"Imyanitov","year":"2021","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"issue":"4","key":"10.1016\/j.ejrad.2022.110499_b0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40291-016-0213-4","article-title":"Distribution of EGFR Mutations in 10,607 Russian Patients with Lung Cancer","volume":"20","author":"Imyanitov","year":"2016","journal-title":"Mol. Diagn. Therapy."},{"issue":"3","key":"10.1016\/j.ejrad.2022.110499_b0120","doi-asserted-by":"crossref","first-page":"e0118432","DOI":"10.1371\/journal.pone.0118432","article-title":"The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets","volume":"10","author":"Saito","year":"2015","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.ejrad.2022.110499_b0125","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.spinee.2021.02.007","article-title":"Using a national surgical database to predict complications following posterior lumbar surgery and comparing the area under the curve and F1-score for the assessment of prognostic capability","volume":"21","author":"DeVries","year":"2021","journal-title":"Spine J.: Off. J. North Am. Spine Soc."},{"issue":"1","key":"10.1016\/j.ejrad.2022.110499_b0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tranon.2017.10.012","article-title":"Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer","volume":"11","author":"Zhang","year":"2018","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ejrad.2022.110499_b0135","doi-asserted-by":"crossref","unstructured":"L. Song, Z. Zhu, L. Mao, X. Li, W. Han, H. Du, H. Wu, W. Song, Z. Jin, Clinical, Conventional CT and Radiomic Feature-Based Machine Learning Models for Predicting ALK Rearrangement Status in Lung Adenocarcinoma Patients, Front. Oncol. 10 (2020) 369. https:\/\/doi.org\/10.3389\/fonc.2020.00369.","DOI":"10.3389\/fonc.2020.00369"},{"issue":"3","key":"10.1016\/j.ejrad.2022.110499_b0140","doi-asserted-by":"crossref","first-page":"1800986","DOI":"10.1183\/13993003.00986-2018","article-title":"Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning","volume":"53","author":"Wang","year":"2019","journal-title":"Eur. Respirat. J."},{"issue":"1","key":"10.1016\/j.ejrad.2022.110499_b0145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1148\/radiol.2016151455","article-title":"CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma","volume":"280","author":"Liu","year":"2016","journal-title":"Radiology."},{"key":"10.1016\/j.ejrad.2022.110499_b0150","doi-asserted-by":"crossref","first-page":"109710","DOI":"10.1016\/j.ejrad.2021.109710","article-title":"CT radiomics-based prediction of anaplastic lymphoma kinase and epidermal growth factor receptor mutations in lung adenocarcinoma","volume":"139","author":"Choe","year":"2021","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2022.110499_b0155","doi-asserted-by":"crossref","first-page":"603882","DOI":"10.3389\/fonc.2021.603882","article-title":"A Machine Learning Model Based on PET\/CT Radiomics and Clinical Characteristics Predicts ALK Rearrangement Status in Lung Adenocarcinoma","volume":"11","author":"Chang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejrad.2022.110499_b0160","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.lungcan.2016.10.010","article-title":"Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers","volume":"102","author":"Chapman","year":"2016","journal-title":"Lung Cancer (Amsterdam, Netherlands)."},{"key":"10.1016\/j.ejrad.2022.110499_b0165","doi-asserted-by":"crossref","unstructured":"A. Ali, R. Goffin, A. Arnold, P.M. Ellis, Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases, Current Oncol. (Toronto, Ont.). 20 (4) (2013) e300\u2013e306. https:\/\/doi.org\/10.3747\/co.20.1481.","DOI":"10.3747\/co.20.1481"},{"issue":"2","key":"10.1016\/j.ejrad.2022.110499_b0170","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10334-017-0653-9","article-title":"2D and 3D texture analysis to differentiate brain metastases on MR images: proceed with caution","volume":"31","author":"B\u00e9resov\u00e1","year":"2018","journal-title":"Magn. Reson. Mater. Phys."},{"key":"10.1016\/j.ejrad.2022.110499_b0175","doi-asserted-by":"crossref","unstructured":"R. Ortiz-Ramon, A. Larroza, E. Arana, D. Moratal, A radiomics evaluation of 2D and 3D MRI texture features to classify brain metastases from lung cancer and melanoma, in: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. 2017 (2017) 493\u2013496. https:\/\/doi.org\/10.1109\/EMBC.2017.8036869.","DOI":"10.1109\/EMBC.2017.8036869"},{"issue":"5","key":"10.1016\/j.ejrad.2022.110499_b0180","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/mrm.26029","article-title":"Differentiating brain metastases from different pathological types of lung cancers using texture analysis of T1 postcontrast MR","volume":"76","author":"Li","year":"2016","journal-title":"Magnet. Reson. Med."},{"issue":"4","key":"10.1016\/j.ejrad.2022.110499_b0185","first-page":"e584","article-title":"Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation","volume":"8","author":"Nardone","year":"2016","journal-title":"Cureus."},{"issue":"1","key":"10.1016\/j.ejrad.2022.110499_b0190","doi-asserted-by":"crossref","first-page":"368","DOI":"10.21037\/tlcr-20-361","article-title":"MRI radiomic signature predicts intracranial progression-free survival in patients with brain metastases of ALK-positive non-small cell lung cancer","volume":"10","author":"Zhao","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"issue":"7","key":"10.1016\/j.ejrad.2022.110499_b0195","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1007\/s00330-020-07614-x","article-title":"Radiomics signature of brain metastasis: prediction of EGFR mutation status","volume":"31","author":"Wang","year":"2021","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2022.110499_b0200","doi-asserted-by":"crossref","first-page":"17913","DOI":"10.1038\/s41598-018-36421-0","article-title":"CT Slice Thickness and Convolution Kernel Affect Performance of a Radiomic Model for Predicting EGFR Status in Non-Small Cell Lung Cancer: A Preliminary Study","volume":"8","author":"Li","year":"2018","journal-title":"Sci. Rep."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X22003497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X22003497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:33:38Z","timestamp":1759995218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X22003497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":40,"alternative-id":["S0720048X22003497"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2022.110499","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differentiating EGFR from ALK mutation status using radiomics signature based on MR sequences of brain metastasis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2022.110499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110499"}}